Pseudohypoaldosteronism type 2

Common Name(s)

Pseudohypoaldosteronism type 2

Psuedohypoaldosteronism type 2 is an inborn error of metabolism. It is characterized by high blood pressure, high levels of potassium in the body, and metabolic acidosis. It is caused by mutations in the WNK1 or WNK4 gene. Treatment may involve dietary restriction of sodium and hydrochlorothiazide.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Pseudohypoaldosteronism type 2" for support, advocacy or research.

Logo
Pseudohypoaldosteronism

We are a group of patients and parents who have been offering support to families with Pseudohypoaldosteronism (PHA) since 2011. PHA is rare yet an important diagnosis to keep on the differential with the patients that have failure to thrive and/or laboratory abnormalities that are associated with it. We would like to find and help those who have a possible diagnosis of PHA, new diagnosis of PHA or have been diagnosed with PHA for a sometime. Our group is formed by patients with PHA type 1, dominant and recessive¬ł and PHA type 2. Our group is composed by people from all over the world who speak several languages. We would love to embrace all those affected as well as anyone seeking information on this rare condition. We are eager to help you all and help the future generation of patients.

https://www.facebook.com/#!/Pseudohypoaldosteronism.PHA

Last Updated: 21 May 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Pseudohypoaldosteronism type 2" for support, advocacy or research.

Logo
Pseudohypoaldosteronism

We are a group of patients and parents who have been offering support to families with Pseudohypoaldosteronism (PHA) since 2011. PHA is rare yet an important diagnosis to keep on the differential with the patients that have failure to thrive and/or laboratory abnormalities that are associated with it. We would like to find and help those who have a possible diagnosis of PHA, new diagnosis of PHA or have been diagnosed with PHA for a sometime. Our group is formed by patients with PHA type 1, dominant and recessive¬ł and PHA type 2. Our group is composed by people from all over the world who speak several languages. We would love to embrace all those affected as well as anyone seeking information on this rare condition. We are eager to help you all and help the future generation of patients.

https://www.facebook.com/#!/Pseudohypoaldosteronism.PHA

Last Updated: 21 May 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Pseudohypoaldosteronism type 2" returned 1 free, full-text research articles on human participants. First 3 results:

Pseudohypoaldosteronism type 2 presenting with hypertension and hyperkalaemia due to a novel mutation in the WNK4 gene.
 

Author(s): A M Brooks, M Owens, J A Sayer, M Salzmann, S Ellard, B Vaidya

Journal: QJM. 2012 Aug;105(8):791-4.

 

Last Updated: 23 Jul 2012

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Pseudohypoaldosteronism type 2" returned 0 free, full-text review articles on human participants.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

There are currently no open clinical trials for this condition.